EM-61476 05.05.2021
Læs pligttekst her ERLEADA® (apalutamide)
Time 0:14-2.04 and 2:50-3:11: Chi KN, Chowdhury S, Bjartell A, et al. J Clin Oncol. 2021; JCO2003488. doi: 10.1200/JCO.20.03488. Online ahead of print. Time 2:20-2.45: Ferro M, Lucarelli G, Crocetto F, et al. Crit Rev Oncol Hematol. 2021; 157:103198.
Prof. Kim Chi talks about what mHSPC is and how androgen receptor targeted therapy can change the prognosis for these patients.
EM-60725 updated 02.06.2021
Læs pligttekst her ZYTIGA® (abirateronacetat)
Læs pligttekst her ERLEADA® (apalutamide)
Prof. Klaus Brasso, introduce the danish treatment guidelines for patients with newly diagnosed mHSPC and raise the question: Is there a difference between chemotherapy and androgen receptor targeted therapy?
EM-61788 updated 02.06.2021
Læs pligttekst her ERLEADA® (apalutamide)